| 38046107 | Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence. | | 2024 |
| 37486145 | Children's Oncology Group's 2023 blueprint for research: Radiation oncology. | | 2023 |
| 35713118 | Clinical outcomes and considerations of gender-affirming care for transgender and gender-diverse pediatric and young adult patients with cancer. | Pediatric Blood and Cancer | 2023 |
| 36367837 | Incidence proportion and prognosis of leptomeningeal disease among patients with breast vs. non-breast primaries. | Neuro Oncol | 2023 |
| 35373902 | Per protocol practice patterns for Children's Oncology Group trials within the radiation oncology community. | Pediatric Blood and Cancer | 2023 |
| 36402744 | Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity. | Neuro-Oncology | 2023 |
| 37722087 | Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization. | J Clin Oncol | 2023 |
| 37703864 | Radiotherapy for Primary Pediatric Central Nervous System Malignancies: Current Treatment Paradigms and Future Directions. | | 2023 |
| 37609311 | Noninvasive molecular subtyping of pediatric low-grade glioma with self-supervised transfer learning. | medRxiv | 2023 |
| 36566593 | Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era. | Neoplasia | 2023 |
| 37260393 | A genomic score to predict local control among patients with brain metastases managed with radiation. | Neuro Oncol | 2023 |
| 37001762 | Feasibility of the Audio-Visual Assisted Therapeutic Ambience in Radiotherapy (AVATAR) System for Anesthesia Avoidance in Pediatric Patients: A Multicenter Trial. | | 2023 |
| 37437812 | Multi-institutional Characterization of Outcomes for Pediatric and Young Adult Patients With High-Risk Myxopapillary Ependymoma After Radiation Therapy. | Int J Radiat Oncol Biol Phys | 2023 |
| 37301262 | Serum miRNA-based signature indicates radiation exposure and dose in humans: A multicenter diagnostic biomarker study. | Radiother Oncol | 2023 |
| 37534382 | Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors. | Pediatr Blood Cancer | 2023 |
| 35100574 | Patient specific distortion detection and mitigation in MR images used for stereotactic radiosurgery. | Physics in Medicine and Biology | 2022 |
| 35384518 | DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis. | Journal of Neuro-Oncology | 2022 |
| 35371522 | Frequency, etiologies, risk factors, and sequelae of falls among patients with brain metastases: A population- and institutional-level analysis. | Neuro-Oncology Practice | 2022 |
| 35733515 | Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children's Oncology Group phase I consortium study. | Neurooncol Adv | 2022 |
| 35472173 | Trends in location of death for individuals with primary brain tumors in the United States. | Neuro Oncol | 2022 |
| 34990779 | A Phase 2 Trial of Response-Based Radiation Therapy for Localized Central Nervous System Germ Cell Tumors: Patterns of Failure and Radiation Dosimetry for Nongerminomatous Germ Cell Tumors. | Int J Radiat Oncol Biol Phys | 2022 |
| 34984469 | Predictors of long-term survival among patients with brain metastases. | Neuro-Oncology | 2022 |
| 34673986 | Peripheral Blood Transcript Signatures after Internal 131I-mIBG Therapy in Relapsed and Refractory Neuroblastoma Patients Identifies Early and Late Biomarkers of Internal 131I Exposures. | Radiation Research | 2022 |
| 35195561 | Breast and Cervical Cancer Screening Disparities in Transgender People. | American Journal of Clinical Oncology: Cancer Clinical Trials | 2022 |
| 34724065 | EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults. | Neuro Oncol | 2022 |
| 34662499 | Anatomic patterns of relapse and progression following treatment with <sup>131</sup> I-MIBG in relapsed or refractory neuroblastoma. | Pediatr Blood Cancer | 2022 |
| 34711456 | Update on Radiation Therapy for Central Nervous System Tumors. | Hematol Oncol Clin North Am | 2022 |
| 34691748 | Emergency department visits and inpatient hospitalizations among older patients with brain metastases: a dual population- and institution-level analysis. | Neuro-Oncology Practice | 2021 |
| 33754454 | Long-term outcomes of pediatric and young adult patients receiving radiotherapy for nonmalignant vascular anomalies. | Pediatric Blood and Cancer | 2021 |
| 33687972 | Intracerebral haemorrhage in patients with brain metastases receiving therapeutic anticoagulation. | J Neurol Neurosurg Psychiatry | 2021 |
| 33536189 | Lipidome-based Targeting of STAT3-driven Breast Cancer Cells Using Poly-l-glutamic Acid-coated Layer-by-Layer Nanoparticles. | Mol Cancer Ther | 2021 |
| 34270348 | Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium. | J Clin Oncol | 2021 |
| 33779742 | Assessment of Simulated SARS-CoV-2 Infection and Mortality Risk Associated With Radiation Therapy Among Patients in 8 Randomized Clinical Trials. | JAMA Netw Open | 2021 |
| 33565268 | Outcomes after first relapse of childhood intracranial ependymoma. | Pediatric Blood and Cancer | 2021 |
| 33664971 | Reirradiation practices for children with diffuse intrinsic pontine glioma. | Neuro-Oncology Practice | 2021 |
| 33823014 | Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas. | Neuro Oncol | 2021 |
| 33259934 | Stereotactic Body Radiation Therapy for Metastatic and Recurrent Solid Tumors in Children and Young Adults. | Int J Radiat Oncol Biol Phys | 2021 |
| 33250303 | Prostate Cancer Screening Patterns Among Sexual and Gender Minority Individuals. | | 2021 |
| 33243479 | A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma. | Int J Radiat Oncol Biol Phys | 2021 |
| 33180096 | Clinical Characteristics, Experiences, and Outcomes of Transgender Patients With Cancer. | JAMA Oncology | 2021 |
| 32960496 | Gliomas, germ cell tumors, and craniopharyngioma. | Pediatr Blood Cancer | 2021 |
| 33068418 | Population-based estimates of survival among elderly patients with brain metastases. | Neuro-Oncology | 2021 |
| 32778521 | Feasibility of hippocampal avoidance whole brain radiation in patients with hippocampal involvement: Data from a prospective study. | Medical Dosimetry | 2021 |
| 33402441 | Seizures Among Patients with Brain Metastases: A Population- and Institutional-level Analysis. | Neurology | 2021 |
| 34569132 | Clinical outcomes for pediatric patients receiving radiotherapy for solid tumor central nervous system metastases. | Pediatric Blood and Cancer | 2021 |
| 34902830 | Gender, Productivity, and Philanthropic Fundraising in Academic Oncology. | Journal of the National Comprehensive Cancer Network : JNCCN | 2021 |
| 34367959 | Harnessing Lactate Metabolism for Radiosensitization. | Frontiers in Oncology | 2021 |
| 32776500 | Practice patterns and recommendations for pediatric image-guided radiotherapy: A Children's Oncology Group report. | Pediatr Blood Cancer | 2020 |
| 31857431 | Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312). | Clin Cancer Res | 2020 |
| 32322066 | Mechanisms and therapeutic implications of hypermutation in gliomas. | Nature | 2020 |